chr4-103028866-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178833.7(SLC9B2):c.1273G>A(p.Val425Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000207 in 1,592,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178833.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC9B2 | NM_178833.7 | c.1273G>A | p.Val425Ile | missense_variant | 11/12 | ENST00000394785.9 | NP_849155.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC9B2 | ENST00000394785.9 | c.1273G>A | p.Val425Ile | missense_variant | 11/12 | 2 | NM_178833.7 | ENSP00000378265 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152010Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000489 AC: 11AN: 225120Hom.: 0 AF XY: 0.0000570 AC XY: 7AN XY: 122832
GnomAD4 exome AF: 0.0000187 AC: 27AN: 1440894Hom.: 0 Cov.: 30 AF XY: 0.0000265 AC XY: 19AN XY: 716698
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152010Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74234
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.1273G>A (p.V425I) alteration is located in exon 11 (coding exon 10) of the SLC9B2 gene. This alteration results from a G to A substitution at nucleotide position 1273, causing the valine (V) at amino acid position 425 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at